\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ physical\\ examination\ \(0\)\
\-\ ace\\ 118\\ u\\/l\\ \\(nl\\ is\\ less\\ than\\ 67\\)\ \(0\)\
\-\ none\\ to\\ date\ \(2\)\
\-\ \\â\\€\\¢\\ ct\\:\\ edema\\ in\\ both\\ frontal\\ lobes\ \(0\)\
\-\ \\â\\€\\¢\\ mr\\:\\ diffuse\\ thickening\\ of\\ the\\ basal\\ meninges\\ with\\ intense\\ enhancement\\.\\ edema\\ at\\ the\\ base\\ of\\ both\\ frontal\\ lobes\\.\\ \\ pan\\ sinusitis\\.\ \(0\)\
\-\ leptomeningeal\\ sarcoid\ \(0\)\
\-\ \\â\\€\\¢\\ tb\\,\\ fungal\\,\\ granulomatous\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ bechets\\ disease\ \(0\)\
\-\ 44\\ year\\ old\\ \\ woman\\ who\\ presents\\ with\\ 3\\ months\\ of\\ headache\\ and\\ decreased\\ visual\\ acuity\\.\ \(1\)\
\-\ chest\\ radiographic\\ is\\ normai\\ and\\ the\\ ct\\ of\\ the\\ chest\\ revealed\\ borderline\\ adenopathy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lobes\\:\\ 0\\.24723275479537812\ \(0\)\
\-\ normai\\:\\ 0\\.23693907862632346\ \(0\)\
\-\ bechets\\:\\ 0\\.2189359763348012\ \(0\)\
\-\ pan\\:\\ 0\\.2044010830874342\ \(0\)\
\-\ frontal\\:\\ 0\\.1907186620490808\ \(0\)\
\-\ 118\\:\\ 0\\.18832278614853987\ \(0\)\
\-\ meninges\\:\\ 0\\.17987059456890367\ \(0\)\
\-\ ace\\:\\ 0\\.17846630736634905\ \(0\)\
\-\ edema\\:\\ 0\\.17673099733642375\ \(0\)\
\-\ borderline\\:\\ 0\\.16748345213229296\ \(0\)\
\-\ both\\:\\ 0\\.16524187793540562\ \(0\)\
\-\ acuity\\:\\ 0\\.16492666946023443\ \(0\)\
\-\ nl\\:\\ 0\\.16259917408161761\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.15665547503394753\ \(0\)\
\-\ chest\\:\\ 0\\.1564120411083606\ \(0\)\
\-\ sinusitis\\:\\ 0\\.15282092724530977\ \(0\)\
\-\ 67\\:\\ 0\\.145733756712537\ \(0\)\
\-\ intense\\:\\ 0\\.13986063647567976\ \(0\)\
\-\ sarcoid\\:\\ 0\\.13894921010358308\ \(0\)\
\-\ date\\:\\ 0\\.1369392473422218\ \(0\)\
\-\ fungal\\:\\ 0\\.13262161706480294\ \(0\)\
\-\ tb\\:\\ 0\\.13192896304611693\ \(0\)\
\-\ granulomatous\\:\\ 0\\.13170212329509623\ \(0\)\
\-\ 44\\:\\ 0\\.1310332540641498\ \(0\)\
\-\ basal\\:\\ 0\\.12677915657828523\ \(0\)\
\-\ visual\\:\\ 0\\.12640810760503418\ \(0\)\
\-\ adenopathy\\:\\ 0\\.12462843996833683\ \(0\)\
\-\ disease\\:\\ 0\\.12438407584182883\ \(0\)\
\-\ the\\:\\ 0\\.11825264709456307\ \(0\)\
\-\ of\\:\\ 0\\.11597652758975659\ \(0\)\
\-\ ct\\:\\ 0\\.11281132240061276\ \(0\)\
\-\ base\\:\\ 0\\.11270206758207536\ \(0\)\
\-\ radiographic\\:\\ 0\\.10992210724441524\ \(0\)\
\-\ headache\\:\\ 0\\.10213472855485159\ \(0\)\
\-\ less\\:\\ 0\\.10079525470978223\ \(0\)\
\-\ thickening\\:\\ 0\\.10079525470978223\ \(0\)\
\-\ revealed\\:\\ 0\\.09714730109776647\ \(0\)\
\-\ mr\\:\\ 0\\.09586586252269373\ \(0\)\
\-\ examination\\:\\ 0\\.0948078668605636\ \(0\)\
\-\ diffuse\\:\\ 0\\.0929142602941454\ \(0\)\
\-\ decreased\\:\\ 0\\.09177295216092901\ \(0\)\
\-\ negative\\:\\ 0\\.09172444983797022\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08823807574838642\ \(0\)\
\-\ months\\:\\ 0\\.08624073699121593\ \(0\)\
\-\ enhancement\\:\\ 0\\.08527795120793777\ \(0\)\
\-\ than\\:\\ 0\\.08398733152333014\ \(0\)\
\-\ who\\:\\ 0\\.08380808314869712\ \(0\)\
\-\ is\\:\\ 0\\.08114889726630092\ \(0\)\
\-\ none\\:\\ 0\\.08096815586755325\ \(0\)\
\-\ physical\\:\\ 0\\.08033540870671492\ \(0\)\
\-\ woman\\:\\ 0\\.0771618815891605\ \(0\)\
\-\ presents\\:\\ 0\\.07127230212664973\ \(0\)\
\-\ and\\:\\ 0\\.06123063763516333\ \(0\)\
\-\ with\\:\\ 0\\.05802291176867789\ \(0\)\
\-\ at\\:\\ 0\\.05596166771520777\ \(0\)\
\-\ year\\:\\ 0\\.04565979920797075\ \(0\)\
\-\ old\\:\\ 0\\.04384921277138693\ \(0\)\
\-\ to\\:\\ 0\\.03703955015850439\ \(0\)\
\-\ in\\:\\ 0\\.03685724156933577\ \(0\)\
